Ramos et al. treated seven HL patients and two patients with anaplastic large cell lymphoma (ALCL) with a CD28 co-stimulated anti-CD30 CAR-T with seven of these patients having previously received BV (45). The gene discussed is TNFRSF8; the disease is Hodgkins lymphoma.